Vizora日本語

Mochida PharmaceuticalMochida Pharmaceutical Co.,Ltd.4534東証プライム医薬品FY ending Mar 2026, consolidated, J-GAAP

Mochida Pharmaceutical FY ending Mar 2024 results

Mochida Pharmaceutical brought in ¥102.9B in revenue.

Out of every ¥100 of sales, about ¥6 is left as operating profit.

Revenue changed -0.4% from the prior year, operating profit -31.8%.

Revenue and profit pattern

Revenue and profit down

Revenue -0.4% · profit -31.8%, calculated from disclosed figures.

Operating leverage: 87.33× (profit growth ÷ revenue growth)

What changed from last year

FY ending Mar 2023 → FY ending Mar 2024

Revenue
-0.4%¥103.3B → ¥102.9B
Gross profit
-5.5%¥55.1B → ¥52.1B
Operating income
-31.8%¥8.51B → ¥5.8B
Net income attributable to owners
-31.6%¥6.65B → ¥4.55B
Operating cash flow
-202.5%¥7.3B → -¥7.48B
Free cash flow
-290.5%¥5.13B → -¥9.78B

Where the money goes

FY ending Mar 2023 → FY ending Mar 2024

Where ¥100 of sales goes

For every ¥100 Mochida Pharmaceutical sells, how much goes where, and how much is kept.

FY ending Mar 2024
Cost of sales
¥49
SG&A
¥45
Operating profit
¥6
Net profit kept
¥4

Annual margin trends

Gross margin50.6%
FY ending Mar 2020: 51.0%51.0%FY ending Mar 2021: 53.2%53.2%FY ending Mar 2022: 54.1%54.1%FY ending Mar 2023: 53.4%53.4%FY ending Mar 2024: 50.6%50.6%FY20FY21FY22FY23FY24
Operating margin5.6%
FY ending Mar 2020: 8.7%8.7%FY ending Mar 2021: 11.7%11.7%FY ending Mar 2022: 13.1%13.1%FY ending Mar 2023: 8.2%8.2%FY ending Mar 2024: 5.6%5.6%FY20FY21FY22FY23FY24
Net margin4.4%
FY ending Mar 2020: 4.5%4.5%FY ending Mar 2021: 8.3%8.3%FY ending Mar 2022: 9.6%9.6%FY ending Mar 2023: 6.4%6.4%FY ending Mar 2024: 4.4%4.4%FY20FY21FY22FY23FY24

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第88期(2025/04/01－2026/03/31)

    ID S100YI282026-06-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第87期(2024/04/01－2025/03/31)

    ID S100W7OB2025-06-27Open

  • EDINET (FSA Japan)

    有価証券報告書－第86期(2023/04/01－2024/03/31)

    ID S100TRAN2024-06-27Open

  • EDINET (FSA Japan)

    有価証券報告書－第85期(2022/04/01－2023/03/31)

    ID S100R7OO2023-06-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第84期(令和3年4月1日－令和4年3月31日)

    ID S100OI5J2022-06-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第83期(令和2年4月1日－令和3年3月31日)

    ID S100LOG52021-06-29Open

Extracted from XBRL: 49 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image